Case report: ADHD and prognosis in tyrosinemia type 1

Neurometabolic disorders such as tyrosinemia type 1 (TYRSN1) may interfere with brain metabolism and show symptoms of attention-deficit hyperactivity disorder (ADHD) in patients treated with the enzyme inhibitor nitisinone [2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione, NTBC]. It has bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Barone, Helene, Elgen, Irene Bircow, Bliksrud, Yngve Thomas, Vangsøy Hansen, Eirik, Skavhellen, Rita Rigmor, Furevik, Magne Ivar, Haavik, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10392124/
https://www.ncbi.nlm.nih.gov/pubmed/37533886
http://dx.doi.org/10.3389/fpsyt.2023.1213590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10392124/
https://www.ncbi.nlm.nih.gov/pubmed/37533886
http://dx.doi.org/10.3389/fpsyt.2023.1213590

Ejemplares similares